In summary, the present study indicated that TH-302 NPs could reduce the expressions of PD-L1 and HIF-1α, promote CD8+ T-cell infiltration in tumour tissues and enhance the efficacy of α-PD-1 immunotherapy by alleviating the hypoxic microenvironment. The gene discussed is CD8A; the disease is neoplasm.